Childhood Low Grade Glioma — Trials

Childhood Low Grade Glioma — Trials · CancerIndex

Clinical trials

Registered studies

44 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03210714	Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)	active not recruiting	Phase 2	20	National Cancer Institute (NCI)NIH	2	Sep 22, 2026	clinicaltrials
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT06666348	Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK(MIRV)	recruiting	Phase 1 / Phase 2	50	St. Justine's HospitalOTHER	1	Aug 11, 2026	clinicaltrials

Data updated 5 days agoSource updated Sep 22, 2026source: clinicaltrials